Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
ExeVir 2026 Company Profile: Valuation, Funding & Investors | PitchBook
ExeVir Bio | VIVES fund
ExeVir on LinkedIn: New data on our variant-proof XVR013m antibody has ...
Fund+ Portfolio Company ExeVir Announces Close of US$50 million / EUR42 ...
Fund+ Company ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to ...
ExeVir Bio announces next generation Covid therapy and looks to expand ...
ExeVir Bio - 2026 Company Profile, Funding, Competitors & Financials ...
News and events - ExeVir
ExeVir on LinkedIn: #biotech #innovation #infectiousdiseases # ...
ExeVir on LinkedIn: Gentse ExeVir krijgt 25 miljoen van Europa voor de ...
ExeVir
ExeVir Bio | 项目信息-36氪
ExeVir bags €23M to take llama-derived COVID-19 drug into clinic ...
Fund+ Portfolio Company ExeVir announces first subjects dosed in Phase ...
ExeVir Appoints New CEO to Advance COVID-19 Therapy
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio | MTA
Belgium’s ExeVir raises €25M from EIB to develop novel COVID-19 ...
Excited to share how ExeVir is tackling infectious diseases and ...
Technology - ExeVir
ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 ...
ExeVir Q&A: the llama-derived antibody that could fight Covid-19
Exevir Bio’s XVR-012 demonstrates neutralization potency against ...
ExeVir doses first patients with llama-derived anti-Covid antibody
Board of directors - ExeVir
Exevir Bio - Wallonie Entreprendre EN - YouTube
ExeVir Bio's XVR013 targets a conserved region in the spike S2 subunit ...
ExeVir on LinkedIn: #infectiousdiseases #covid19 #dengue #bioequity # ...
Our team - ExeVir
ExeVir on LinkedIn: #idwgs #therapeutics #infectiousdiseases #dengue # ...
ExeVir start klinische proeven met "lamamedicijn" tegen COVID-19 - Medi ...
Belgium: ExeVir lands European venture debt financing to develop novel ...
Phase I clinical study evaluates safety and pharmacokinetics of ExeVir ...
Exevir on Toyhouse
ExeVir on LinkedIn: #eswi2023 #sarscov2 #covid19 #therapeutic # ...
V-Bio invests into ExeVir Bio to accelerate development of new ...
#infectiousdiseases | ExeVir
ExeVir on LinkedIn: #eccmid2023 #covid19 #therapeutic #medicines # ...
Can llama antibodies beat COVID-19? Belgium's ExeVir raises 23m euros ...
ExeVir on LinkedIn: #bioequity #partnering #investment #covid19 # ...
Biotech Rising Stars - ExeVir - YouTube
ExeVir | LinkedIn
ExeVir Snags $50 Million to Take Llama Antibody into First In-Human ...
Board of directors_2 - ExeVir
Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio
Funding round-up: BioVersys, ExeVir Bio, Volta Medical, Ganymed ...
flanders.bio on LinkedIn: ExeVir Bio forges ahead with unique next ...
ExeVir on LinkedIn: Welcome! You are invited to join a webinar: The ...
ExeVir Bio and Nona Biosciences Join Forces in Collaboration Agreement
Belgische coronamedicijnbelofte Exevir tankt 17 miljoen euro bij ...
ExeVir on LinkedIn: #antibodytechnology #covid19 #prevention # ...
Home - ExeVir
Angelique Boerboom - Head Of Projects & Partnerships at ExeVir | The Org
How Llama nanobodies fight COVID-19 | ExeVir
ExeVir on LinkedIn: Member spotlight: ExeVir uses llama-derived ...
ExeVir on LinkedIn: #worldvaccineconference #innovationinhealthcare # ...
Mithra gaat coronamedicijn van Gentse start-up ExeVir produceren ...
Member spotlight: ExeVir uses llama-derived antibodies to protect the ...
Exevir - Sambrinvest
ExeVir on LinkedIn: #bioequity #exevir
vib.be - Op weg naar een COVID-19 geneesmiddel
企业资讯 | 诺纳生物：与ExeVir Bio达成合作协议，加速开发传染病创新疗法医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Excited to start a new challenge at ExeVir! | Manuel Aramburu Álvarez ...
Top 54 Life Science Startups in 2024
🙌 We are delighted to announce that Michael Garrett will be joining ...
ExeVir's Llama-Derived Antibody Embarks on Human COVID-19 Trials - BioSpace
ExeVir's variant-proof clinical lead candidate antibody for the ...
Sambrinvest entre au capital d'ExeVir, biotech belge qui développe un ...
6 biomimicry companies harnessing nature for drug development
Top 15 medical and healthcare startups in Belgium 2026
Le site liégeois de Mithra va produire le traitement contre le Covid de ...
ExeVir. Bio BV Chief medical officer Dominique Tersago, Dr. Bert ...
Charlotte Bonami posted on LinkedIn
Clinical Debut for ExeVir's Llama Antibody Treatment
首款羊駝新冠抗體進臨床！ 比利時ExeVir Bio奈米抗體展開臨床一期試驗-環球生技月刊
#networking #partnering #pharma #biotech #therapeutics #drugdiscovery ...
VIB on LinkedIn: #exevir #eib #covid19 #therapy #futurepandemics # ...
Home - V-Bio
Chiara Lonigro posted on LinkedIn
